EFFECT OF THERAPEUTIC LASER IN THE MANAGEMENT OF DIABETIC NEUROPATHY PAIN

被引:0
|
作者
Jannu, Chiranjeevi [1 ]
Devi, Vahini [2 ]
Suganthirababu, Prathap [3 ]
Puchchakayala, Goverdhan [4 ]
机构
[1] Vaagdevi Coll Physiotherapy, Warangal, Telangana, India
[2] Saveetha Univ, Chennai, Tamil Nadu, India
[3] Gulf Med Univ, Coll Allied Hlth Sci, Ajman, U Arab Emirates
[4] Vaagdevi Coll Pharm, Hanamkonda, Telangana, India
关键词
Diabetes mellitus (DM); diabetic neuropathy (DN); low level laser irradiation(LLLI); Mc Gill Pain Questionnaire(MPQ); modified toronto clinical neuropathy score (mTCNS);
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Diabetes mellitus is characterized by absolute or relative insulin deficiency, hyperglycemia and development of diabetic specific micro vascular complications in retina, kidney and nerves. Micro vascular disease significantly contributes to increased morbidity and indirectly contributes to mortality through diabetic neuropathy. Pain may occur with either acute or chronic neuropathy. It results from small fibre damage. Lancinating, neuralgia - type will follow ectopic generation of nerve impulses, whereas chronic, burning pain is due to nerve is chaemia. Therapeutic laser (TL) is gaining much importance in reducing neuropathic pain Objective: To find out the effect of therapeutic laser in the management of diabetic neuropathy pain by comparing with regular medication. Methods: 50 patients were selected by using lottery method of simple random sampling procedure into two groups (Group A 25 and Group B 25) equally. Group A was treated with medications (oral hypoglycemic, analgesics and anti - depressant drugs) for four weeks. Group B was treated with TL for 10mins for 4 times a week for 4 weeks with a dosage of 4J/cm( 2). Their pre & post treatment values were extracted basing on modified Toronto clinical neuropathy score (mTCNS). Results: Both groups pre and post test values were extracted for four weeks and analyzed individually by using Wilcoxon signed rank test. Both groups showed variation in their scores individually. When compared between the groups by using Mann Whitney U - test, group B showed remarkable variation when compared with group A. Conclusion: TL has shown remarkable reduction in pain score of group B when compared with group A. TL is one of the best treatment modality in reducing neuropathic pain. Physiotherapists can gain access with this treatment to proliferate their practice in treating diabetic neuropathic pain.
引用
收藏
页码:142 / 144
页数:3
相关论文
共 50 条
  • [31] CLINICAL AND THERAPEUTIC REMARKS ON DIABETIC NEUROPATHY
    POZZA, G
    SAIBENE, V
    COMI, G
    MUSCH, B
    CANAL, N
    MUSCLE & NERVE, 1978, 1 (06) : 512 - 513
  • [32] DIABETIC NEUROPATHY - CONTROLLED THERAPEUTIC TRIALS
    SHUMAN, CR
    GILPIN, SF
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1954, 227 (06): : 612 - 617
  • [33] Inflammation: Therapeutic Targets for Diabetic Neuropathy
    Zhou, Jiyin
    Zhou, Shiwen
    MOLECULAR NEUROBIOLOGY, 2014, 49 (01) : 536 - 546
  • [34] The effect of transdermal nitroglycerin on pain control in diabetic patients with peripheral neuropathy
    Taheri A.
    Farbood A.
    Heshmat R.
    Samadi A.
    Khashayar P.
    Qorbani M.
    Ghorbani M.
    Ebrahimi Khaneqah G.
    Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [35] Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents
    Lopes, L. S.
    Pereira, S. S.
    Silva, L. L.
    Figueiredo, K. A.
    Moura, B. A.
    Almeida, F. R. C.
    Sousa, F. C. F.
    LIFE SCIENCES, 2009, 84 (3-4) : 105 - 110
  • [36] Pathogenesis of pain in peripheral diabetic neuropathy
    Calcutt N.A.
    Backonja M.M.
    Current Diabetes Reports, 2007, 7 (6) : 429 - 434
  • [37] Tramadol for the treatment of the pain of diabetic neuropathy
    Moulin, D
    NEUROLOGY, 1999, 52 (06) : 1301 - 1301
  • [38] Decoding the Pain Paradox in Diabetic Neuropathy
    Selvarajah, Dinesh
    Wilkinson, Iain
    Davis, J.
    Sankar, A.
    Gandhi, R.
    Tracey, Irene
    Tesfaye, Solomon
    DIABETES, 2015, 64 : A51 - A51
  • [39] Alleviation of pain in painful diabetic neuropathy
    Tajti, Jnos
    Szok, Delia
    Majlath, Zsofia
    Csati, Anett
    Petrovics-Balog, Anna
    Vecsei, Laszlo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 753 - 764
  • [40] Contribution of mitochondria to pain in diabetic neuropathy
    Hernandez-Beltran, Natalia
    Moreno, Carlos B.
    Maria Gutierrez-Alvarez, Angela
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (01): : 25 - 32